• Valproic acid produced marked reduction in myoclonus in a patient with dyssynergia cerebellaris myoclonica (DCM), resulting in substantial functional improvement. These results justify a trial of valproic acid in patients with DCM who are disabled by myoclonus.
Somerville ER, Olanow CW. Valproic Acid: Treatment of Myoclonus in Dyssynergia Cerebellaris Myoclonica. Arch Neurol. 1982;39(8):527–528. doi:10.1001/archneur.1982.00510200069016
Browse and subscribe to JAMA Network podcasts!
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: